About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Rare Disease Genetic Testing Market Size & Analysis Report, 2033
Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease Type (Immunological Disorders, Cardiovascular Disorders, Neurological Disease, Endocrine and Metabolism Disorders Diseases, Hematological Diseases, Dermatological Disease, Others), By Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests), By Technology (Next-Generation Sequencing, Sanger Sequencing, PCR Based Testing, Array Based Testing, FISH, Others), By End-User (Hospitals and Clinics, Research Laboratories and CROs, Diagnostic Laboratories) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI54770DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Rare Disease Genetic Testing Market Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Immunological Disorders
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disease
        1. By Value
      5. Endocrine and Metabolism Disorders Diseases
        1. By Value
      6. Hematological Diseases
        1. By Value
      7. Dermatological Disease
        1. By Value
      8. Others
        1. By Value
    3. By Specialty
      1. Introduction
        1. Specialty By Value
      2. Molecular Genetic Tests
        1. By Value
      3. Chromosomal Genetic Tests
        1. By Value
      4. Biochemical Genetic Tests
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. PCR Based Testing
        1. By Value
      5. Array Based Testing
        1. By Value
      6. FISH
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Laboratories and CROs
        1. By Value
      4. Diagnostic Laboratories
        1. By Value
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Immunological Disorders
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disease
        1. By Value
      5. Endocrine and Metabolism Disorders Diseases
        1. By Value
      6. Hematological Diseases
        1. By Value
      7. Dermatological Disease
        1. By Value
      8. Others
        1. By Value
    3. By Specialty
      1. Introduction
        1. Specialty By Value
      2. Molecular Genetic Tests
        1. By Value
      3. Chromosomal Genetic Tests
        1. By Value
      4. Biochemical Genetic Tests
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. PCR Based Testing
        1. By Value
      5. Array Based Testing
        1. By Value
      6. FISH
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Laboratories and CROs
        1. By Value
      4. Diagnostic Laboratories
        1. By Value
    6. U.S.
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Immunological Disorders
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disease
          1. By Value
        5. Endocrine and Metabolism Disorders Diseases
          1. By Value
        6. Hematological Diseases
          1. By Value
        7. Dermatological Disease
          1. By Value
        8. Others
          1. By Value
      2. By Specialty
        1. Introduction
          1. Specialty By Value
        2. Molecular Genetic Tests
          1. By Value
        3. Chromosomal Genetic Tests
          1. By Value
        4. Biochemical Genetic Tests
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. PCR Based Testing
          1. By Value
        5. Array Based Testing
          1. By Value
        6. FISH
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Laboratories and CROs
          1. By Value
        4. Diagnostic Laboratories
          1. By Value
    7. Canada
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Immunological Disorders
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disease
        1. By Value
      5. Endocrine and Metabolism Disorders Diseases
        1. By Value
      6. Hematological Diseases
        1. By Value
      7. Dermatological Disease
        1. By Value
      8. Others
        1. By Value
    3. By Specialty
      1. Introduction
        1. Specialty By Value
      2. Molecular Genetic Tests
        1. By Value
      3. Chromosomal Genetic Tests
        1. By Value
      4. Biochemical Genetic Tests
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. PCR Based Testing
        1. By Value
      5. Array Based Testing
        1. By Value
      6. FISH
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Laboratories and CROs
        1. By Value
      4. Diagnostic Laboratories
        1. By Value
    6. U.K.
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Immunological Disorders
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disease
          1. By Value
        5. Endocrine and Metabolism Disorders Diseases
          1. By Value
        6. Hematological Diseases
          1. By Value
        7. Dermatological Disease
          1. By Value
        8. Others
          1. By Value
      2. By Specialty
        1. Introduction
          1. Specialty By Value
        2. Molecular Genetic Tests
          1. By Value
        3. Chromosomal Genetic Tests
          1. By Value
        4. Biochemical Genetic Tests
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. PCR Based Testing
          1. By Value
        5. Array Based Testing
          1. By Value
        6. FISH
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Laboratories and CROs
          1. By Value
        4. Diagnostic Laboratories
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Immunological Disorders
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disease
        1. By Value
      5. Endocrine and Metabolism Disorders Diseases
        1. By Value
      6. Hematological Diseases
        1. By Value
      7. Dermatological Disease
        1. By Value
      8. Others
        1. By Value
    3. By Specialty
      1. Introduction
        1. Specialty By Value
      2. Molecular Genetic Tests
        1. By Value
      3. Chromosomal Genetic Tests
        1. By Value
      4. Biochemical Genetic Tests
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. PCR Based Testing
        1. By Value
      5. Array Based Testing
        1. By Value
      6. FISH
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Laboratories and CROs
        1. By Value
      4. Diagnostic Laboratories
        1. By Value
    6. China
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Immunological Disorders
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disease
          1. By Value
        5. Endocrine and Metabolism Disorders Diseases
          1. By Value
        6. Hematological Diseases
          1. By Value
        7. Dermatological Disease
          1. By Value
        8. Others
          1. By Value
      2. By Specialty
        1. Introduction
          1. Specialty By Value
        2. Molecular Genetic Tests
          1. By Value
        3. Chromosomal Genetic Tests
          1. By Value
        4. Biochemical Genetic Tests
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. PCR Based Testing
          1. By Value
        5. Array Based Testing
          1. By Value
        6. FISH
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Laboratories and CROs
          1. By Value
        4. Diagnostic Laboratories
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Immunological Disorders
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disease
        1. By Value
      5. Endocrine and Metabolism Disorders Diseases
        1. By Value
      6. Hematological Diseases
        1. By Value
      7. Dermatological Disease
        1. By Value
      8. Others
        1. By Value
    3. By Specialty
      1. Introduction
        1. Specialty By Value
      2. Molecular Genetic Tests
        1. By Value
      3. Chromosomal Genetic Tests
        1. By Value
      4. Biochemical Genetic Tests
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. PCR Based Testing
        1. By Value
      5. Array Based Testing
        1. By Value
      6. FISH
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Laboratories and CROs
        1. By Value
      4. Diagnostic Laboratories
        1. By Value
    6. UAE
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Immunological Disorders
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disease
          1. By Value
        5. Endocrine and Metabolism Disorders Diseases
          1. By Value
        6. Hematological Diseases
          1. By Value
        7. Dermatological Disease
          1. By Value
        8. Others
          1. By Value
      2. By Specialty
        1. Introduction
          1. Specialty By Value
        2. Molecular Genetic Tests
          1. By Value
        3. Chromosomal Genetic Tests
          1. By Value
        4. Biochemical Genetic Tests
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. PCR Based Testing
          1. By Value
        5. Array Based Testing
          1. By Value
        6. FISH
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Laboratories and CROs
          1. By Value
        4. Diagnostic Laboratories
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Immunological Disorders
        1. By Value
      3. Cardiovascular Disorders
        1. By Value
      4. Neurological Disease
        1. By Value
      5. Endocrine and Metabolism Disorders Diseases
        1. By Value
      6. Hematological Diseases
        1. By Value
      7. Dermatological Disease
        1. By Value
      8. Others
        1. By Value
    3. By Specialty
      1. Introduction
        1. Specialty By Value
      2. Molecular Genetic Tests
        1. By Value
      3. Chromosomal Genetic Tests
        1. By Value
      4. Biochemical Genetic Tests
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing
        1. By Value
      3. Sanger Sequencing
        1. By Value
      4. PCR Based Testing
        1. By Value
      5. Array Based Testing
        1. By Value
      6. FISH
        1. By Value
      7. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Laboratories and CROs
        1. By Value
      4. Diagnostic Laboratories
        1. By Value
    6. Brazil
      1. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Immunological Disorders
          1. By Value
        3. Cardiovascular Disorders
          1. By Value
        4. Neurological Disease
          1. By Value
        5. Endocrine and Metabolism Disorders Diseases
          1. By Value
        6. Hematological Diseases
          1. By Value
        7. Dermatological Disease
          1. By Value
        8. Others
          1. By Value
      2. By Specialty
        1. Introduction
          1. Specialty By Value
        2. Molecular Genetic Tests
          1. By Value
        3. Chromosomal Genetic Tests
          1. By Value
        4. Biochemical Genetic Tests
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing
          1. By Value
        3. Sanger Sequencing
          1. By Value
        4. PCR Based Testing
          1. By Value
        5. Array Based Testing
          1. By Value
        6. FISH
          1. By Value
        7. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Laboratories and CROs
          1. By Value
        4. Diagnostic Laboratories
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Rare Disease Genetic Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Quest Diagnostics Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Centogene N.V.
    3. 3billion Inc.
    4. Invitae Corp.
    5. Arup Laboratories
    6. Eurofins Scientific
    7. Ambry Genetics
    8. Strand Life Sciences
    9. Perkin Elmer, Inc.
    10. Health Network Laboratories
    11. Opko Health, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Genetic Testing Market Size The global genetic testing market size was worth USD 14.82 billion in 2021 and is projected to reach USD 36.11 billion by 2030, growing at a CAGR of 10% during the forecast period (2022-2030).  Genetic testing
Buy Now
Global Report
Rare Disease Diagnostics Market Size The global rare disease diagnostics market size was valued at USD 1,152.35 million in 2024 and is projected to reach from USD 1,312.86 million in 2025 to USD 3,726.57 million by 2033, growing at a CAGR of 14.30%
Buy Now
Global Report
The global respiratory disease testing market size was valued at USD 6140 million in 2019 and is expected to grow at a CAGR of 8.2% during the forecast study period. Respiratory disease testing aids in determining the type of lung disorder and
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.